An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. A drug for the treatment of a rare disease (affecting fewer than 200,000 people in the US or fewer than 5 in every 10,000 individuals in the EU) or for a disease not likely to generate sufficient profit to justify Research and Development costs.
Source: EU Clinical Trials Register
